Vestor Capital’s Gilead Sciences GILD Stock Holding History

Vestor Capital’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-1,605	Closed	-$94K	–	215
2020 Q4	$94K	Buy	1,605 +100	+7%	+$6.03K	0.01%	135
2020 Q3	$95K	Buy	+1,505	New	+$104K	0.01%	103
2020 Q1	$132K	Buy	1,765 +260	+17%	+$18K	0.03%	94
2019 Q4	$98K	Hold	1,505	–	–	0.01%	119
2019 Q3	$95K	Sell	1,505 -295	-16%	-$19.3K	0.02%	102
2019 Q2	$122K	Buy	1,800 +50	+3%	+$3.29K	0.02%	81
2019 Q1	$114K	Buy	+1,750	New	+$116K	0.02%	90

Other funds holding GILD

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Vestor Capital's GILD Position: Q1 2021 in Review

Vestor Capital sold out of Gilead Sciences (GILD) in Q1 2021, closing a stake of 1,605 shares — an estimated $94K sold.

Vestor Capital first reported a position in GILD in Q1 2019 and held it in 7 quarters. The position peaked at $132K in Q1 2020. 1,567 funds tracked by Wall St. Rank hold GILD as of Q1 2021.

Vestor Capital reported no remaining Gilead Sciences position as of Q1 2021 after selling out during the quarter.
Vestor Capital sold 1,605 Gilead Sciences shares in Q1 2021, an estimated $94K.
Vestor Capital first reported a position in Gilead Sciences in Q1 2019 and held it in 7 quarters.
Vestor Capital's Gilead Sciences position peaked at $132K in Q1 2020.
1,567 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2021.

Based on Vestor Capital's 13F filing for Q1 2021, filed 14 May 2021.